Ovarian Neoplasms: all 2,757 studies
Page 24 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCompletedNCT01253681Phase 1
- Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted CoelioscopyCompletedNCT01247779Not applicable
- Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease RemissionCompletedNCT01246440Phase 2
- Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal MetastasisCompletedNCT01242436Not applicable
- Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesCompletedNCT01242072Phase 1
- Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01238770Phase 1/2
- A Prospective Trial of COXEN Chemotherapy PredictionWithdrawnNCT01228942Not applicable
- MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)TerminatedNCT01227941Phase 1
- Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesCompletedNCT01226316Phase 1
- Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation TherapyActive, not recruitingNCT01223248Phase 3
- Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerCompletedNCT01220154Phase 1
- Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian CancerSuspendedNCT01218490Phase 3
- Health and Coping Prior to Ovarian Cancer SurgeryCompletedNCT01213771Not applicable
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCompletedNCT01204749Phase 3
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTerminatedNCT01202890Phase 1
- Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian CancerCompletedNCT01196559Phase 2
- Short Non-coding RNA Biomarkers of Predisposition to Ovarian CancerStatus unknownNCT01187602
- Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian CancerStatus unknownNCT01180504Phase 2
- Early Detection of Cancers in Low Resource CountriesStatus unknownNCT01178736
- Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian CarcinomaTerminatedNCT01177501Phase 1
- Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian CancerTerminatedNCT01175967
- Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyTerminatedNCT01175772Phase 2
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)TerminatedNCT01170650Phase 3
- Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT01166737Not applicable
- Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian CancerCompletedNCT01164995Phase 2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian CancerCompletedNCT01148758Phase 1
- Incidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerCompletedNCT01139957
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerWithdrawnNCT01138137Phase 1
- Autologous OC-DC Vaccine in Ovarian CancerCompletedNCT01132014Early Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube CancerWithdrawnNCT01131039Phase 2
- Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346Not applicable
- Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer PatientsCompletedNCT01124435Phase 2
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk WomenCompletedNCT01121640Not applicable
- A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian CancerCompletedNCT01113957Phase 2
- Biobehavioral-Cytokine Interactions in Ovarian CancerCompletedNCT01113112
- A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late RelapseCompletedNCT01111903Phase 1/2
- Study of Oral ENMD-2076 Administered to Patients With Ovarian CancerCompletedNCT01104675Phase 2
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1
- A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerCompletedNCT01095848Phase 1
- Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian CancerTerminatedNCT01095367Not applicable
- Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian CancerCompletedNCT01091636Phase 2/3
- Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel ObstructionTerminatedNCT01083537Phase 1/2
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT01080521
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01074411Phase 1
- Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182Status unknownNCT01074398
- Safety of BKM120 Monotherapy in Advanced Solid Tumor PatientsCompletedNCT01068483Phase 1
- Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerCompletedNCT01065441Phase 1/2
- Pathway to Diagnosis of Ovarian CancerStatus unknownNCT01061619
- Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01047891Phase 2
- How Our Immune System Can Help Fight CancerCompletedNCT01042847
- M. D. Anderson Symptom Inventory - Ovarian CancerCompletedNCT01037751
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT01033292Phase 2
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerCompletedNCT01033123Phase 2
- Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian CancerWithdrawnNCT01017809Not applicable
- A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian CancerTerminatedNCT01016054Phase 1
- Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian CancerCompletedNCT01004380Phase 1
- Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelWithdrawnNCT01000896Phase 1
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00989651Phase 1
- Study of Paclitaxel in Patients With Ovarian CancerCompletedNCT00989131Phase 3
- Ovarian Cancer Risk Estimation in Patients With Pelvic MassCompletedNCT00987649
- Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian CancerCompletedNCT00986206
- A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian CancerStatus unknownNCT00982631Phase 1
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
- A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic CancersCompletedNCT00964756Phase 1
- Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial CancerStatus unknownNCT00964626Phase 2
- Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)CompletedNCT00959582Phase 1
- Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot StudyCompletedNCT00946140
- Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal CavityWithdrawnNCT00942838Phase 1
- Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only RelapseTerminatedNCT00926107Phase 2
- Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian CancerTerminatedNCT00919984Phase 2
- Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian CancerCompletedNCT00900679Not applicable
- Prostaglandin Metabolite in Urine Samples From Patients With Ovarian CancerCompletedNCT00900523
- Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial CancerStatus unknownNCT00900289
- YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyTerminatedNCT00899093
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00897039
- Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyCompletedNCT00892736Phase 1
- Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian CancerTerminatedNCT00889733Phase 1/2
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)CompletedNCT00889382Phase 1/2
- Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian CancerStatus unknownNCT00886717Phase 1/2
- Assessment of Screening Modalities for Gynecologic CancersCompletedNCT00879840
- Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian CancerCompletedNCT00877253Phase 1
- Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-typeCompletedNCT00861120Phase 2
- Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian CancerTerminatedNCT00856453Not applicable
- Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian CancerStatus unknownNCT00855998
- Screening and Identification of Ovarian CancersStatus unknownNCT00854399Not applicable
- The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell ExpressionStatus unknownNCT00854282Not applicable
- Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian CancerCompletedNCT00850772Phase 3
- Cancer Screening and Prevention Program for High Risk WomenCompletedNCT00849199
- Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerCompletedNCT00846612Phase 1
- p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian CancerCompletedNCT00844506Phase 2
- Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian CancerWithdrawnNCT00842582Phase 1
- A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsCompletedNCT00841191Phase 1/2
- Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00838656Phase 2
- A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian CancerCompletedNCT00831636Phase 1/2
- Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)CompletedNCT00829959
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal CavityCompletedNCT00825201Phase 1
- Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2